Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Erlotinib can cause hair loss and texture changes.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Linkus cough syrup is effective and safe with no side effects or toxicity in rats.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Melatonin stops melanin production after tyrosinase action, with cyclic GMP mimicking this effect.

Both topiramate and divalproex sodium effectively reduce migraine frequency and are generally well-tolerated.

The method accurately measures Finasteride and Tamsulosin in tablets without interference.

A three-year-old girl has hair loss despite treatment with selenium sulfide shampoo and anti-fungal medication.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Leflunomide can cause skin ulcers, and stopping it can lead to healing.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Compound 4 is a promising treatment for hair loss with low toxicity.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.